Julie Pique
Overview
Explore the profile of Julie Pique including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khatib L, Pique J, Ciano-Petersen N, Criton G, Birzu C, Aubart M, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Feb;
12(3):e200378.
PMID: 39999393
Background And Objectives: Abnormal brain MRI is associated with poor outcomes in anti-N-methyl-d-aspartate receptor encephalitis (NMDARE). We aimed to characterize the lesions on brain MRI in NMDARE and to assess...
2.
Ramdani R, Pique J, Deschamps R, Ciron J, Maillart E, Audoin B, et al.
Mult Scler
. 2025 Jan;
13524585241311435.
PMID: 39812323
Background: The clinical course of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is variable. However, robust markers of poor outcome and/or relapse risk are still missing. Objective: To evaluate the...
3.
Mittelman A, Pique J, Desportes V, Deiva K, Poulat A, Marignier R
Dev Med Child Neurol
. 2024 Oct;
67(4):529-536.
PMID: 39412046
Aim: To describe the impact of paediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) on academic and cognitive outcomes. Method: This was an observational, retrospective, and descriptive single-centre study, carried out...
4.
Deschamps R, Guillaume J, Ciron J, Audoin B, Ruet A, Maillart E, et al.
Neurology
. 2024 Jul;
103(3):e209624.
PMID: 38991174
Background And Objectives: Because myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently identified autoimmune disorder, the natural history of MOGAD is still not well described. The objective of this...
5.
Deschamps R, Papeix C, Ayrignac X, Bourre B, Ciron J, Cohen M, et al.
Rev Neurol (Paris)
. 2024 Jul;
180(8):711-714.
PMID: 38969609
No abstract available.
6.
Collongues N, Durand-Dubief F, Lebrun-Frenay C, Audoin B, Ayrignac X, Bensa C, et al.
Mult Scler
. 2024 Feb;
30(7):899-924.
PMID: 38357870
Background: Epidemiological data reveal that 45% of persons with multiple sclerosis (PwMS) in France are more than 50 years. This population more than 50 is more susceptible to cancer, and...
7.
Chen J, Flanagan E, Pittock S, Stern N, Tisavipat N, Bhatti M, et al.
Am J Ophthalmol
. 2023 Feb;
252:213-224.
PMID: 36822570
Purpose: To evaluate the effectiveness of plasma exchange (PLEX) for optic neuritis (ON). Methods: We conducted an international multicenter retrospective study evaluating the outcomes of ON following PLEX. Outcomes were...
8.
Rode J, Pique J, Maarouf A, Ayrignac X, Bourre B, Ciron J, et al.
J Neurol Neurosurg Psychiatry
. 2023 Jan;
94(4):309-313.
PMID: 36600666
Background: To characterise the response to treatment of inaugural optic neuritis (ON) in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Methods: We searched the French MOGAD database for adults...
9.
Vukusic S, Marignier R, Ciron J, Bourre B, Cohen M, Deschamps R, et al.
Mult Scler
. 2022 Nov;
29(1):37-51.
PMID: 36345839
Background: In 2020, the French Multiple Sclerosis (MS) Society (SFSEP) decided to develop a national evidence-based consensus on pregnancy in MS. As neuromyelitis optica spectrum disorders (NMOSD) shares a series...
10.
Vukusic S, Carra-Dalliere C, Ciron J, Maillart E, Michel L, Leray E, et al.
Mult Scler
. 2022 Nov;
29(1):11-36.
PMID: 36317497
Objective: The objective of this study was to develop evidence-based recommendations on pregnancy management for persons with multiple sclerosis (MS). Background: MS typically affects young women in their childbearing years....